Ketorolac Improves Graft Patency After Coronary Artery Bypass Grafting: A Propensity-Matched Analysis

The use of ketorolac after coronary artery bypass grafting was associated with a lower rate of angiographically proven graft closure and suggests a mechanistic (improved graft patency) explanation for the previously reported survival benefit of ketorolac.